120 related articles for article (PubMed ID: 24520991)
1. Current strategies for designing antidotes against botulinum neurotoxins.
Patel K; Cai S; Singh BR
Expert Opin Drug Discov; 2014 Mar; 9(3):319-33. PubMed ID: 24520991
[TBL] [Abstract][Full Text] [Related]
2. Strategies to design inhibitors of Clostridium botulinum neurotoxins.
Cai S; Singh BR
Infect Disord Drug Targets; 2007 Mar; 7(1):47-57. PubMed ID: 17346211
[TBL] [Abstract][Full Text] [Related]
3. Challenges in searching for therapeutics against Botulinum Neurotoxins.
Pirazzini M; Rossetto O
Expert Opin Drug Discov; 2017 May; 12(5):497-510. PubMed ID: 28271909
[TBL] [Abstract][Full Text] [Related]
4. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
5. Gaining ground: assays for therapeutics against botulinum neurotoxin.
Hakami RM; Ruthel G; Stahl AM; Bavari S
Trends Microbiol; 2010 Apr; 18(4):164-72. PubMed ID: 20202845
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxins and botulism: a novel therapeutic approach.
Thanongsaksrikul J; Chaicumpa W
Toxins (Basel); 2011 May; 3(5):469-88. PubMed ID: 22069720
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
Yu YZ; Zhang SM; Ma Y; Zhu HQ; Wang WB; Du Y; Zhou XW; Wang RL; Wang S; Yu WY; Huang PT; Sun ZW
Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619
[TBL] [Abstract][Full Text] [Related]
9. Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins.
Capková K; Salzameda NT; Janda KD
Toxicon; 2009 Oct; 54(5):575-82. PubMed ID: 19327377
[TBL] [Abstract][Full Text] [Related]
10. A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin.
Maslanka SE; Lúquez C; Dykes JK; Tepp WH; Pier CL; Pellett S; Raphael BH; Kalb SR; Barr JR; Rao A; Johnson EA
J Infect Dis; 2016 Feb; 213(3):379-85. PubMed ID: 26068781
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs.
Barker D; Gillum KT; Niemuth NA; Kodihalli S
PLoS One; 2019; 14(9):e0222670. PubMed ID: 31527885
[TBL] [Abstract][Full Text] [Related]
12. Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.
Wilson BA; Ho M
Curr Top Med Chem; 2014; 14(18):2081-93. PubMed ID: 25335885
[TBL] [Abstract][Full Text] [Related]
13. New targets in the search for preventive and therapeutic agents for botulism.
Anniballi F; Lonati D; Fiore A; Auricchio B; De Medici D; Locatelli CA
Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1075-86. PubMed ID: 25089560
[TBL] [Abstract][Full Text] [Related]
14. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW
Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
[TBL] [Abstract][Full Text] [Related]
15. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.
Dembek ZF; Smith LA; Rusnak JM
Disaster Med Public Health Prep; 2007 Nov; 1(2):122-34. PubMed ID: 18388640
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
[TBL] [Abstract][Full Text] [Related]
17. The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication.
Dickerson TJ; Janda KD
ACS Chem Biol; 2006 Jul; 1(6):359-69. PubMed ID: 17163773
[TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication.
Li B; Peet NP; Butler MM; Burnett JC; Moir DT; Bowlin TL
Molecules; 2010 Dec; 16(1):202-20. PubMed ID: 21193845
[TBL] [Abstract][Full Text] [Related]
19. Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.
Machamer JB; Vazquez-Cintron EJ; O'Brien SW; Kelly KE; Altvater AC; Pagarigan KT; Dubee PB; Ondeck CA; McNutt PM
Mol Med; 2022 Jun; 28(1):61. PubMed ID: 35659174
[TBL] [Abstract][Full Text] [Related]
20. The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison.
Willis B; Eubanks LM; Dickerson TJ; Janda KD
Angew Chem Int Ed Engl; 2008; 47(44):8360-79. PubMed ID: 18844202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]